CHENANGO COUNTY – Norwich Pharmaceutical has a long history of caring for its community, and that history continued throughout the COVID-19 pandemic.

According to Norwich Pharmaceuticals Senior Site Director Tami Watson, Norwich Pharmaceutical is an Alvogen company which originated in the City of Norwich in 1887.

“The Alvogen manufacturing facility is located just north of Norwich on State Highway 12 and was constructed in the late 1970’s. Over the past sixyears, there has been significant investment in the facility, bringing it into modern standards of pharmaceutical production.”

Watson said Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world.

The company is headquartered in Reykjavik, Iceland with commercial operations in 20 countries with 1,700 employees with 550 in the US of which 300 are based in the Norwich facility, and operates four manufacturing and development hubs in the U.S., Korea and Taiwan.

Watson discussed the progression and challenges of Alvogen in 2020 and said an ongoing capital project and creating a COVID-19 team were some of the major initiatives. “In addition, Alvogen received a Workforce Development Institute Grant in 2020 applied to the managerial coaching program.”

“We have an on-going three-year capital project underway in support of the high complexity products manufactured at the facility,” Watson said, “During the initial phase of the pandemic, we delayed due to COVID-19.”